Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00823095 · ClinicalTrials.gov registry record · Phase 2
Topical Nitric Oxide Trial in Chronic Non-Healing Wounds
A Phase 2 study, sponsored by Loma Linda University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 7
- Enrollment target
NCT00823095 is a Phase 2 study that was terminated before completion, run by Loma Linda University. The registered enrollment target is 7 participants.
The verdict
NCT00823095, a Phase 2 study, was terminated before completion, sponsored by Loma Linda University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 7 participants
- Enrollment target
Study Summary
To determine the effects of topically applied ViaNOx-H for 8 hours daily for 2 weeks on the reduction of the bio-burden in biofilms on chronic non-healing wounds as recorded by measurements of wound size and wound culture.
Interventions
- DRUG Nitric Oxide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2005-12 |
| Est. Completion | 2008-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00823095
The ClinicalTrials.gov registry entry for NCT00823095 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nitric Oxide is the first listed.
NCT00823095 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00823095 about?
NCT00823095 is a clinical study titled "Topical Nitric Oxide Trial in Chronic Non-Healing Wounds". To determine the effects of topically applied ViaNOx-H for 8 hours daily for 2 weeks on the reduction of the bio-burden in biofilms on chronic non-healing wounds as recorded by measurements of wound size and wound culture.
What is the current status of trial NCT00823095?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2005-12. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00823095?
The interventions under investigation include: Nitric Oxide (DRUG).
Who is sponsoring clinical trial NCT00823095?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.